Cyclopentenone Prostaglandins with Dienone Structure Promote Cross-Linking of the Chemoresistance-Inducing Enzyme Glutathione Transferase P1-1
暂无分享,去创建一个
[1] G. Aldini,et al. Delta12-prostaglandin J2 as a product and ligand of human serum albumin: formation of an unusual covalent adduct at His146. , 2010, Journal of the American Chemical Society.
[2] J. A. Murray,et al. Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia , 2009, PloS one.
[3] N. Kitteringham,et al. A mechanistic investigation into the irreversible protein binding and antigenicity of p-phenylenediamine. , 2009, Chemical research in toxicology.
[4] D. Townsend,et al. Novel Role for Glutathione S-Transferase π , 2009, Journal of Biological Chemistry.
[5] A. Townsend,et al. Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane. , 2008, Carcinogenesis.
[6] Luigi Frati,et al. Inhibition of Trail Gene Expression by Cyclopentenonic Prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2 in T Lymphocytes , 2007, Molecular Pharmacology.
[7] R. Curi,et al. LipoCardium: endothelium-directed cyclopentenone prostaglandin-based liposome formulation that completely reverses atherosclerotic lesions. , 2007, Atherosclerosis.
[8] K. Tew,et al. Redox in redux: Emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. , 2007, Biochemical pharmacology.
[9] G. Aldini,et al. Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. , 2007, Biochemistry.
[10] D. Pérez-Sala,et al. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival. , 2007, Archives of biochemistry and biophysics.
[11] P. Cassidy,et al. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. , 2006, Carcinogenesis.
[12] T. Snape,et al. Induction of Apoptosis in Estrogen Receptor-Negative Breast Cancer Cells by Natural and Synthetic Cyclopentenones: Role of the IκB Kinase/Nuclear Factor-κB Pathway , 2006, Molecular Pharmacology.
[13] Y. Jiang,et al. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2–ASK1 signals , 2006, Oncogene.
[14] W. Miller,et al. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4 , 2006, Annals of Hematology.
[15] B. van de Water,et al. Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling. , 2006, Biochemical pharmacology.
[16] Konstantinos Stamatakis,et al. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton. , 2005, Journal of the American Society of Nephrology : JASN.
[17] L. Ghibelli,et al. Proapoptotic activity of new glutathione S-transferase inhibitors. , 2005, Cancer research.
[18] K. Stamatakis,et al. Protein Thiol Modification by 15-deoxy-Δ12,14-Prostaglandin J2 Addition in Mesangial Cells: Role in the Inhibition of Pro-inflammatory Genes , 2004, Molecular Pharmacology.
[19] W. Atkins,et al. A novel antioxidant role for ligandin behavior of glutathione S-transferases: attenuation of the photodynamic effects of hypericin. , 2004, Biochemistry.
[20] W. Fischer,et al. Protein Disulfide Bond Formation in the Cytoplasm during Oxidative Stress* , 2004, Journal of Biological Chemistry.
[21] A. Fisher,et al. Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Townsend,et al. Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta 12,14prostaglandin J2 (15-d-PGJ2). , 2004, Biochemistry.
[23] F. Cañada,et al. Molecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-Δ12,14-prostaglandin J2* , 2003, Journal of Biological Chemistry.
[24] K. Lauber,et al. Cyclopentenone Prostaglandins Induce Lymphocyte Apoptosis by Activating the Mitochondrial Apoptosis Pathway Independent of External Death Receptor Signaling 1 , 2003, The Journal of Immunology.
[25] S. Cuzzocrea,et al. 2‐Cyclopenten‐1‐one and prostaglandin J2 reduce restenosis after balloon angioplasty in rats: role of NF‐κB , 2003, FEBS letters.
[26] H. Masutani,et al. Thioredoxin as a Molecular Target of Cyclopentenone Prostaglandins* , 2003, Journal of Biological Chemistry.
[27] C. Gong,et al. Glutathion S transferase pi indicates chemotherapy resistance in breast cancer. , 2003, The Journal of surgical research.
[28] Dolores Pérez-Sala,et al. 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. , 2001, The Journal of biological chemistry.
[29] A. Sinz,et al. Mapping protein interfaces with a fluorogenic cross-linker and mass spectrometry: application to nebulin-calmodulin complexes. , 2001, Biochemistry.
[30] G. Melino,et al. Modulation of GST P1‐1 activity by polymerization during apoptosis , 2000, Journal of cellular biochemistry.
[31] Y. Kawamoto,et al. Cyclopentenone Prostaglandins as Potential Inducers of Phase II Detoxification Enzymes , 2000, The Journal of Biological Chemistry.
[32] W Chiu,et al. EMAN: semiautomated software for high-resolution single-particle reconstructions. , 1999, Journal of structural biology.
[33] P. van Bladeren,et al. Interactions of prostaglandin A2 with the glutathione-mediated biotransformation system. , 1999, Biochemical pharmacology.
[34] M. Pincus,et al. Regulation of JNK signaling by GSTp , 1999, The EMBO journal.
[35] F. Cañada,et al. Analogs of farnesylcysteine induce apoptosis in HL‐60 cells , 1998, FEBS letters.
[36] P. van Bladeren,et al. Interactions of alpha, beta-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. , 1997, Chemico-biological interactions.
[37] A. Caccuri,et al. Redox forms of human placenta glutathione transferase. , 1991, The Journal of biological chemistry.
[38] L. Roberts,et al. Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2. , 1990, Biochemistry.
[39] Do-Hee Kim,et al. 15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells. , 2009, Annals of the New York Academy of Sciences.
[40] W. Atkins,et al. Bivalent inhibitors of glutathione S-transferase: the effect of spacer length on isozyme selectivity. , 2006, Bioorganic & medicinal chemistry letters.
[41] L. Pease,et al. In vitro recombination and mutagenesis by overlap extension PCR. , 1996, Methods in molecular biology.
[42] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.